Studies of parvovirus vaccination in the dog: the performance of live attenuated feline parvovirus vaccines.
The performance of three live attenuated feline parvovirus vaccines licensed for use in the dog was studied. At the end of the primary vaccination course 67 per cent of dogs had inadequate antibody levels (less than or equal to 32) as measured by a haemagglutination inhibition test. Interference by maternal antibody accounted for some of the failures but the fact that there was no significant difference in performance between dogs vaccinated at 12 weeks or 16 weeks of age indicated that maternal antibody was not the only factor.
Thompson
H
H
Department of Veterinary Pathology, University of Glasgow Veterinary School, Bearsden.
McCandlish
I A
IA
Cornwell
H J
HJ
Macartney
L
L
Maxwell
N S
NS
Weipers
A F
AF
Wills
I R
IR
Black
J A
JA
Mackenzie
A C
AC
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis*; D004285:Dogs / Q000276:immunology*; D006385:Hemagglutination Inhibition Tests / Q000662:veterinary; D010321:Parvoviridae / Q000276:immunology*; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines